NEW YORK, Nov. 2 – Siemens, the German electronics giant, and biotechnology company and countrymate november have announced plans to co-develop a novel DNA-based electrochemical diagnostic system and marking Siemens’ debut into genomics.

Terms of the agreement, originally announced in September, call for november to develop the biochemical and electrochemical methods while Medical Solutions, a Siemens business unit, will be responsible for the device itself. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.